Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Nilasha Ghosh

11PUBLICATIONS
42CO-AUTHORS
AutoimmunityTransplantation immunologyToxicology (incl. clinical toxicology)Rheumatology and arthritisGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study.

|Nov 15, 2025
Arthroplasty Joint Histology and Surgical Outcomes in Patients on Immune Checkpoint Inhibitors: A Single-Center Case Series.

Karmela K Chan, Nilasha Ghosh, Carlos Aude

|Aug 27, 2025
Use of Apremilast for the Treatment of Immune Checkpoint Inhibitor Psoriasis and Psoriatic Arthritis.

Nilasha Ghosh, Pankti Reid, Jeffrey A Sparks

|Sep 25, 2023
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.

Charles P Hannon, Susan M Goodman, Matthew S Austin

|Sep 25, 2023
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.

Charles P Hannon, Susan M Goodman, Matthew S Austin

|Jun 24, 2023
Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis.

Nilasha Ghosh, Pankti Reid, Carlos Andres Aude

Pageof 2

Frequent Collaborators

5 joint publications

Anne R Bass

4 joint publications

Susan M Goodman

3 joint publications

Karmela Kim Chan

3 joint publications

Carlos Aude

2 joint publications

Laura C Cappelli

2 joint publications

Deanna P Jannat-Khah

2 joint publications

Delamo Isaac Bekele

2 joint publications

Jeffrey A Sparks

2 joint publications

Joshua F Baker

2 joint publications

Pankti Reid

Frequent Collaborators

5 joint publications

Anne R Bass

4 joint publications

Susan M Goodman

3 joint publications

Karmela Kim Chan

3 joint publications

Carlos Aude